Target Binding Site Detail
| Target General Information | Top | ||||
|---|---|---|---|---|---|
| Target ID | T94131 | Target Info | |||
| Target Name | HUMAN PI3-kinase gamma (PIK3CG) | ||||
| Synonyms | p120-PI3K; p110gamma; Serine/threonine protein kinase PIK3CG; PtdIns-3-kinase subunit p110-gamma; PtdIns-3-kinase subunit gamma; PtdIns-3-kinase p110; Phosphoinositol-3 kinase; Phosphoinositide-3-kinase catalytic gamma polypeptide; Phosphoinositide 3-Kinase gamma; Phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit, gamma isoform; Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform; Phosphatidylinositol 4,5-bisphosphate 3-kinase 110 kDa catalytic subunit gamma; PI3Kgamma; PI3K-gamma; PI3K; PI3-kinase subunit gamma; PI3-kinase p110 subunit gamma | ||||
| Gene Name | PIK3CG | ||||
| Biochemical Class | Kinase | ||||
| UniProt ID | |||||
| Ligand General Information | Top | ||||
|---|---|---|---|---|---|
| Ligand Name | 3-Methyl-1-(oxan-4-yl)-8-pyridin-3-yl-imidazo[4,5-c]quinolin-2-one | Ligand Info | |||
| Canonical SMILES | CN1C2=CN=C3C=CC(=CC3=C2N(C1=O)C4CCOCC4)C5=CN=CC=C5 | ||||
| InChI | 1S/C21H20N4O2/c1-24-19-13-23-18-5-4-14(15-3-2-8-22-12-15)11-17(18)20(19)25(21(24)26)16-6-9-27-10-7-16/h2-5,8,11-13,16H,6-7,9-10H2,1H3 | ||||
| InChIKey | QPTLAOOZWOLYLB-UHFFFAOYSA-N | ||||
| PubChem Compound ID | 134163712 | ||||
| Drug Binding Sites of Target | Top | |||||
|---|---|---|---|---|---|---|
| PDB ID: 6FH5 PI3Kg IN COMPLEX WITH Compound 7 | ||||||
| Method | X-ray diffraction | Resolution | 2.84 Å | Mutation | No | [1] |
| PDB Sequence |
ESQAFQRQLT
155 ALIGYDVTDV165 SNVHDDELEF175 TRRGLVTPRM185 AEVASRDPKL195 YAMHPWVTSK 205 PLPEYLWKKI215 ANNCIFIVIH225 RTTSQTIKVS236 PDDTPGAILQ246 DFVLRVCGRD 278 EYLVGETPIK288 NFQWVRHCLK298 NGEEIHVVLD308 TPPDPALDEV318 RKVSLWDCDR 359 KFRVKIRGID369 IPVTVFVEAN386 IQHGQQVLCQ396 RRTSPKPFTE406 EVLWNVWLEF 416 SIKIKDLPKG426 ALLNLQIYCQ459 LLYYVNLLLI469 DHRFLLRRGE479 YVLHMWQISF 497 NADKLTSATN507 PDKENSMSIS517 ILLDNYCHPI527 ALPKRAEMPN549 QLRKQLEAII 559 ATDPLNPLTA569 EDKELLWHFR579 YESLKHPKAY589 PKLFSSVKWG599 QQEIVAKTYQ 609 LLARREVWDQ619 SALDVGLTMQ629 LLDCNFSDEN639 VRAIAVQKLE649 SLEDDDVLHY 659 LLQLVQAVKF669 EPYHDSALAR679 FLLKRGLRNK689 RIGHFLFWFL699 RSEIAQSRHY 709 QQRFAVILEA719 YLRGCGTAML729 HDFTQQVQVI739 EMLQKVTLDI749 KSLSASSQVI 764 SQLKQKLENL774 QNLPESFRVP786 YDPGLKAGAL796 AIEKCKVMAS806 KKKPLWLEFK 816 CADPTALSNE826 TIGIIFKHGD836 DLRQDMLILQ846 ILRIMESIWE856 TESLDLCLLP 866 YGCISTGDKI876 GMIEIVKDAT886 TIAKIQQKDE905 VLNHWLKEKS915 PTEEKFQAAV 925 ERFVYSCAGY935 CVATFVLGIG945 DRHNDNIMIT955 ETGNLFHIDF965 GHERVPFVLT 988 PDFLFVMGTS998 GTSPHFQKFQ1010 DICVKAYLAL1020 RHHTNLLIIL1030 FSMMLMTGMK 1045 EDIEYIRDAL1055 TVGKNEEDAK1065 KYFLDQIEVC1075 RDKGWTVQFN1085 WF |
|||||
|
|
||||||
| PDB ID: 6GQ7 PI3Kg IN COMPLEX WITH INH | ||||||
| Method | X-ray diffraction | Resolution | 2.84 Å | Mutation | No | [2] |
| PDB Sequence |
ESQAFQRQLT
155 ALIGYDVTDV165 SNVHDDELEF175 TRRGLVTPRM185 AEVASRDPKL195 YAMHPWVTSK 205 PLPEYLWKKI215 ANNCIFIVIH225 RTTSQTIKVS236 PDDTPGAILQ246 DFVLRVCGRD 278 EYLVGETPIK288 NFQWVRHCLK298 NGEEIHVVLD308 TPPDPALDEV318 RKVSLWDCDR 359 KFRVKIRGID369 IPVTVFVEAN386 IQHGQQVLCQ396 RRTSPKPFTE406 EVLWNVWLEF 416 SIKIKDLPKG426 ALLNLQIYCQ459 LLYYVNLLLI469 DHRFLLRRGE479 YVLHMWQISF 497 NADKLTSATN507 PDKENSMSIS517 ILLDNYCHPI527 ALPKRAEMPN549 QLRKQLEAII 559 ATDPLNPLTA569 EDKELLWHFR579 YESLKHPKAY589 PKLFSSVKWG599 QQEIVAKTYQ 609 LLARREVWDQ619 SALDVGLTMQ629 LLDCNFSDEN639 VRAIAVQKLE649 SLEDDDVLHY 659 LLQLVQAVKF669 EPYHDSALAR679 FLLKRGLRNK689 RIGHFLFWFL699 RSEIAQSRHY 709 QQRFAVILEA719 YLRGCGTAML729 HDFTQQVQVI739 EMLQKVTLDI749 KSLSASSQVI 764 SQLKQKLENL774 QNLPESFRVP786 YDPGLKAGAL796 AIEKCKVMAS806 KKKPLWLEFK 816 CADPTALSNE826 TIGIIFKHGD836 DLRQDMLILQ846 ILRIMESIWE856 TESLDLCLLP 866 YGCISTGDKI876 GMIEIVKDAT886 TIAKIQQKDE905 VLNHWLKEKS915 PTEEKFQAAV 925 ERFVYSCAGY935 CVATFVLGIG945 DRHNDNIMIT955 ETGNLFHIDF965 GHERVPFVLT 988 PDFLFVMGTS998 GTSPHFQKFQ1010 DICVKAYLAL1020 RHHTNLLIIL1030 FSMMLMTGMK 1045 EDIEYIRDAL1055 TVGKNEEDAK1065 KYFLDQIEVC1075 RDKGWTVQFN1085 WF |
|||||
|
|
||||||
| References | Top | ||||
|---|---|---|---|---|---|
| REF 1 | Discovery and Optimisation of a Novel Series of 3-Cinnoline Carboxamides as Orally Bioavailable, Highly Potent and Selective Ataxia Telangiectasia Mutated (ATM) inhibitors | ||||
| REF 2 | PI3Kg IN COMPLEX WITH INH | ||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.